Search Results (15)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets. | Academic Article |
Why?
|
| An evaluation of the dilution method for identifying metabolism-dependent inhibitors of cytochrome P450 enzymes. | Academic Article |
Why?
|
| Comparative oncology approach to drug repurposing in osteosarcoma. | Academic Article |
Why?
|
| Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer. | Academic Article |
Why?
|
| Fluorescence-based viability assay for studies of reactive drug intermediates. | Academic Article |
Why?
|
| A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge. | Academic Article |
Why?
|
| Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. | Academic Article |
Why?
|
| Intestinal alkaline phosphatase administration in newborns decreases systemic inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model. | Academic Article |
Why?
|
| Intestinal alkaline phosphatase to treat necrotizing enterocolitis. | Academic Article |
Why?
|
| Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. | Academic Article |
Why?
|
| Everolimus improves the efficacy of dasatinib in PDGFRa-driven glioma. | Academic Article |
Why?
|
| Radiation-induced changes in intestinal and tissue-nonspecific alkaline phosphatase: implications for recovery after radiation therapy. | Academic Article |
Why?
|
| Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia. | Academic Article |
Why?
|
| Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model. | Academic Article |
Why?
|
| NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. | Academic Article |
Why?
|